KOR

e-Article

Efficacy and safety of the proposed bevacizumab biosimilar BAT1706 compared with reference bevacizumab in patients with advanced nonsquamous non-small cell lung cancer: A randomized, double-blind, phase III study
Document Type
Article
Source
In: Cancer Medicine. (Cancer Medicine, November 2023, 12(22):20847-20863)
Subject
Language
English
ISSN
20457634